Notification on Accurate Identification of Cookies-Branded Medical Cannabis Products

Mörfelden-Walldorf, October 21st, 2024 – The Cansativa Group is the sole licensee of Cookies-branded cannabis products in Germany. The Cookies product line available in Germany includes four varieties of dried cannabis flowers: Apples and Bananas, Medellín, Blanco, and Hawaiian Rain. As the authorized distributor, we ensure that every product bearing the Cookies name meets the highest standards of quality and authenticity.

It has been brought to our attention that certain products on the market may have labeling that could be misleading. We want to clarify that any product resembling Cookies-branded offerings but not sold through Cansativa is not an authorized Cookies branded product.

Cansativa expressly reserves the right to take legal action against any possible infringement in this context. We have also informed our partner, Cookies Creative Consulting & Promotions, Inc., about this circumstance in order to give them the opportunity to prosecute a possible infringement as well. Cansativa is the only company authorized to market, among other things, the brand “Cookies” in connection with the packaging and/or production of medical cannabis products in Germany.

To prevent confusion with the names of other manufacturers, we hereby list the cultivars that will be exclusively marketed under the Cookies brand until the end of the year 2024: Cookies Medizinalcannabisblüten A&B 22/1, Cookies Medizinalcannabisblüten Medellin 22/1, Cookies Medizinalcannabisblüten Hawaian Rain 22/1 and Cookies Medizinalcannabisblüten Blanco THC/CBD.

About Cansativa Group

Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medical cannabis market. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medical cannabis in the context of pain therapies.

With regard to the reclassification of cannabis in Germany, the Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute, and brand cannabis. The company is also committed to cannabis education. With the vision “We enable Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.

For more information, visit www.cansativa.de/en.

Nicole Borges Steeb
External Affairs
+49 6105 96 380 69

nicole.borgessteeb@cansativa.de


Notification on Accurate Identification of Cookies-Branded Medical Cannabis Products

Mörfelden-Walldorf, October 21st, 2024 – The Cansativa Group is the sole licensee of Cookies-branded cannabis products in Germany. The Cookies product line available in Germany includes four varieties of dried cannabis flowers: Apples and Bananas, Medellín, Blanco, and Hawaiian Rain. As the authorized distributor, we ensure that every product bearing the Cookies name meets the highest standards of quality and authenticity.

It has been brought to our attention that certain products on the market may have labeling that could be misleading. We want to clarify that any product resembling Cookies-branded offerings but not sold through Cansativa is not an authorized Cookies branded product.

Cansativa expressly reserves the right to take legal action against any possible infringement in this context. We have also informed our partner, Cookies Creative Consulting & Promotions, Inc., about this circumstance in order to give them the opportunity to prosecute a possible infringement as well. Cansativa is the only company authorized to market, among other things, the brand “Cookies” in connection with the packaging and/or production of medical cannabis products in Germany.

To prevent confusion with the names of other manufacturers, we hereby list the cultivars that will be exclusively marketed under the Cookies brand until the end of the year 2024: Cookies Medizinalcannabisblüten A&B 22/1, Cookies Medizinalcannabisblüten Medellin 22/1, Cookies Medizinalcannabisblüten Hawaian Rain 22/1 and Cookies Medizinalcannabisblüten Blanco THC/CBD.

About Cansativa Group

Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medical cannabis market. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medical cannabis in the context of pain therapies.

With regard to the reclassification of cannabis in Germany, the Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute, and brand cannabis. The company is also committed to cannabis education. With the vision “We enable Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.

For more information, visit www.cansativa.de/en.

Nicole Borges Steeb
External Affairs
+49 6105 96 380 69

nicole.borgessteeb@cansativa.de


Thanks to Cansativa: Cookies products are now available in Germany!

Mörfelden-Walldorf, September 25, 2024 – The Cansativa Group, the leading import and distribution platform for medical cannabis in Germany, has established an exclusive
partnership with the world’s most famous cannabis brand, Cookies. Starting Wednesday, these products will be exclusively available through Cansativa. The partnership will be celebrated at the event “Yes, we can Cannabizz,” on Thursday, November 14, 2024, from 3:00 PM in Berlin – with Berner, Co-Founder and CEO of Cookies, also in attendance.

As the sole licensee for Cookies products in Germany, Cansativa is importing a selection of high-quality cannabis products for the medical cannabis market. The products are grown by RPK Biopharma, a 100% subsidiary of the SOMAÍ Group.

The Cookies product line available in Germany includes four varieties of dried cannabis flowers: Apples and Bananas, Medellín, Blanco, and Hawaiian Rain. The first product, Apples and Bananas, will be available from September 25, 2024, in selected pharmacies. Cookies is the world’s most renowned cannabis company. It was founded in 2010 by Billboard-charting rapper and entrepreneur Berner, together with Bay Area breeder and cultivator Jai.

Yes, we can Cannabizz.

The American cannabis entrepreneur Berner will be present on Thursday, November 14, 2024, from 3:00 PM at the ALICE Rooftop & Garden in West Berlin to discuss the future of the international cannabis market together with Germany’s most exciting cannabis duo, Benedikt and Jakob Sons. Additional leading experts, such as Finn Age Hänsel (Founder and CEO of Sanity Group), will provide insights from the industry, medical field, and patient perspectives. The focus will be on “How to shape the future of Cannabis,” with particular emphasis on the challenges and opportunities of the German and international cannabis markets.

Further information about the event can be found HERE. If you would like to attend in person, please contact Katarina at katarina@thetrailblazers.de / +49 1734120544.

About Cansativa Group
Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medical cannabis market. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medical cannabis in the context of pain therapies.

With regard to the reclassification of cannabis in Germany, the Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute and brand cannabis. The company is also committed to cannabis education. With the vision “We enable Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.

For more information, visit www.cansativa.de/en.

About Cookies
Cookies is the most globally recognized cannabis company; founded in 2010 by Billboard-charting rapper and entrepreneur Berner and Bay Area breeder and cultivator Jai. The company creates game-changing genetics and offers a collection of over 70 proprietary cannabis cultivars and more than 2,000 products. Headquartered in San Francisco, the company is actively involved in advocacy and social impact initiatives to enrich communities disproportionately impacted by the War on Drugs. Cookies opened its first retail store in 2018 in Los Angeles, has since expanded to over 70 retail locations in over 20 markets across 6 countries, and was recently named one of America’s Hottest Brands of 2021 by Ad Age; the first cannabis brand to ever receive this accolade.

To learn more about Cookies, visit https://cookies.co/, and to learn more about Cookies CBD, visit shop.cookies.co

 

Press Contact Cansativa
Katarina Jörg
+49 1734120544
katarina@thetrailblazers.de

Press Contact Cookies
Emily Meshell
+1-318-564-8195
em@mygrasslands.com


Cansativa and Cookies team up to bring Cookies products into the German medical cannabis market.

Mörfelden-Walldorf, 11th of June 2024 – The Cansativa Group, the leading import and distribution platform of medical cannabis in Germany, has established an exclusive partnership with the most globally recognized cannabis brand, Cookies. As the sole licensee for Cookies products in Germany, Cansativa will import a premium selection of cannabis products for the medical cannabis market. The products are cultivated and supplied exclusively by RPK Biopharma, a 100% subsidiary of SOMAÍ Group.

The collaboration between Cansativa and Cookies marks a significant milestone in the German medical cannabis industry, as patients gain access to a range of high-quality products meticulously crafted to meet stringent quality, efficacy, and safety standards.
The Cookies product line available in Germany includes four dried cannabis flower varieties: Apples and Bananas, Medellín, Blanco, and Hawaiian Rain. The first product Apples and Bananas will be available nationwide in pharmacies by prescription from 1st of August 2024 and adhere to EU-GMP and GACP standards. Leveraging a meticulous selection process for cannabis genetics and a state-of-the-art cultivator, Cookies stands for reliable and superior products for both recreational and medical cannabis uses.

Patients can find detailed information about THC content and therapeutic applications of Cookies products at their doctor’s office or local pharmacy.

“We are thrilled about our collaboration with Cookies, which allows Cansativa to broaden the spectrum of top-tier cannabis varieties in the medical market in Germany,” says Benedikt Sons, Co-founder, managing director, and CEO of Cansativa. “Internationally, Cookies stands for high-quality cannabis products made with scientific precision and years of expertise. For patients in Germany who use medical cannabis for therapeutic purposes, Cookies offers a unique new range of medical cannabis varieties.”

“Germany is an exciting market for me for multiple reasons, the energy and vibe around legalization is contagious. Also, in the early 2000’s, I had my music randomly break on a radio station and took a trip to Germany and experienced the culture first hand, in my early 20’s. This partnership with Cansativa is about to be a powerful one, and I will be making a trip out to Germany for the launch this summer. I can’t express how ready I am to share our genetics with Germany.” – Gilbert Milam, Co-founder and CEO of Cookies, also known as rapper with stage name Berner.

“Working with Cansativa and Cookies, both heavy weights in the business, to bring Cookies to Germany is a huge milestone for RPK Biopharma and also signifies the deep commitment we have to produce the very best cannabis flower and products. The European cannabis market is at a tipping point with Germany having just announced decriminalization of cannabis. We’re excited to partner with Cansativa to bring one of the best-known cannabis brands in the world to patients in Germany” says Tom Flow, Managing Director of RPK Biopharma, a 100% subsidiary of SOMAÍ Group.

“SOMAÍ continues to support German patients by offering one of the most iconic flower brands Cookies through the Cansativa group,” says Michael Sassano, the Founder and Interim CEO of SOMAÍ Group.

About Cansativa Group
Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medical cannabis market. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medical cannabis in the context of pain therapies.

With regard to the reclassification of cannabis in Germany, the Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute and brand cannabis. The company is also committed to cannabis education. With the vision “We enable Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.

For more information, visit www.cansativa.de/en.

About Cookies
Cookies is the most globally recognized cannabis company; founded in 2010 by Billboard-charting rapper and entrepreneur Berner and Bay Area breeder and cultivator Jai. The company creates game-changing genetics and offers a collection of over 70 proprietary cannabis cultivars and more than 2,000 products. Headquartered in San Francisco, the company is actively involved in advocacy and social impact initiatives to enrich communities disproportionately impacted by the War on Drugs. Cookies opened its first retail store in 2018 in Los Angeles, has since expanded to over 70 retail locations in over 20 markets across 6 countries, and was recently named one of America’s Hottest Brands of 2021 by Ad Age; the first cannabis brand to ever receive this accolade.

To learn more about Cookies, visit https://cookies.co/.

About SOMAÍ Group
SOMAÍ Group is a leading EU-GMP European biotech company with a global footprint of distribution for the largest and most advanced EU-GMP-certified cannabinoid-containing portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based products.
SOMAÍ Group owns a state-of-the-art manufacturing facility SOMAÍ Pharmaceuticals and indoor cultivation RPK Biopharma in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of the few vertically integrated companies in the EU able to cater to the diverse needs of fast-growing European cannabis markets.

Press Contact Cansativa
Angela Koch
+49 (0)151 51067532 cansativa@schoesslers.com

Press Contact Cookies
Emily Meshell +1-318-564-8195 em@mygrasslands.com

Press Contact RPK Biopharma / SOMAÍ Group
Nataliia Garnina
hello@somaipharma.eu


Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany

Cronos Group Inc. (“Cronos”), a publicly traded global cannabis company, and Cansativa GmbH (“Cansativa”), the German market leader for medical cannabis, have entered into a supply agreement for the import, marketing, and distribution of the PEACE NATURALS® product line in Germany. The first of three products will be delivered to pharmacies on 1st of November 2023. Two further products will launch by November 2023. Pre-orders via the online shop of Cansativa are available for pharmacies now.

The PEACE NATURALS® brand is returning to the German market after a brief absence. While it was available sporadically, Cansativa and Cronos have the shared goal to keep the brand and its products available in Germany over the long term.

The PEACE NATURALS® product range that will be available in Germany initially includes three cannabis dried flower varieties: GMO Cookies, Cocoa Bomba and Space Cake. In the Canadian cannabis market, Cronos has won awards for its products and innovations in a number of product categories. Cronos has invested heavily in research and development for its genetic breeding and tissue culture program, which have resulted in cultivars medical patients can count on for quality and consistency. Cronos has a sophisticated flower genetics and cultivar program, headed by industry-leading R&D professionals who have brough best-selling strains to consumers in medical and adult-use markets.

Patients can obtain relevant information, including THC levels and cannabinoid specifics ofPEACE NATURALS® products, from their physician, local pharmacy or a Cansativa partner pharmacy.

“We are very happy to bring such a successful brand like PEACE NATURALS® back to Germany,” says Benedikt Sons, founder and CEO of Cansativa. “Together with our partner Cronos, we want to ensure a reliable and consistent supply of these high-quality products for cannabis patients.”

“We intend to establish our PEACE NATURALS® brand as a top medical brand in Germany,” says Mike Gorenstein, Chairman and CEO of Cronos. “We are proud to bring high-quality, medical cannabis to this market and look forward to establishing PEACE NATURALS® as a trusted brand in Germany.”

About Cansativa Group

Cansativa Group was founded in 2017 by the brothers Benedikt and Jakob Sons in Frankfurt am Main, Germany. Cansativa has the largest platform for the most desirable cannabis products and brands which makes it the leader in the medicinal cannabis market. Since the award of the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, it is the only company with approval for the distribution of medicinal cannabis from German cultivation. Through a network of around 2000 pharmacies, Cansativa currently supplies around 300,000 patients in Germany with medicinal cannabis in the context of pain therapies.

With regard to the planned legalisation of cannabis, the Cansativa Group sees itself as a pioneer in the democratisation of the cannabis market. Cansativa has the necessary infrastructure and expertise to safely import, store, license, distribute and brand cannabis. The company is also committed to cannabis education. With the vision “We enable

Cannabis”, Cansativa sees itself as a driving force of the cannabis industry in Germany.

Further information www.cansativa-group.de

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about importing, distributing and marketing the PEACE NATURALS® product line; anticipated delivery and launch dates of such products; the availability of the PEACE NATURALS® product line in Germany and the consistency and reliability of the supply thereof; the quality and consistency of Cronos cultivars; the PEACE NATURALS® brand and its positioning in Germany; Cansativa’s impact on the cannabis industry in Germany; and the Cronos brand portfolio. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results and performance or achievements expressed or implied by those Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, each of which has been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Press contacts:

Cansativa Group
Ioana Freise, External Affairs
pr@cansativa.de

Cronos Group
Emily Whalen, Media Relations
media.relations@thecronosgroup.com